E-LIB Suche - Ergebnisse für: Marín-Jiménez, I

1

P232 Common variable immunodeficiency-associated enteropath..:

Miranda-Bautista, J ; Di Natale, M ; Mejía González, M A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i571-i572 , 2024

Link: https://doi.org/10.1093/..

2

P969 Unveiling the molecular mechanisms of the combination ..:

Marín-Jiménez, I ; Sierra-Ausín, M ; Letosa-Abián, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1758-i1758 , 2024

Link: https://doi.org/10.1093/..

3

P822 Therapeutic Management And Risk Of Colectomy In Patien..:

Mesonero Gismero, F ; López-García, A ; Miranda-Bautista, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1530-i1532 , 2024

Link: https://doi.org/10.1093/..

4

DOP60 Prevalence of undiagnosed inflammatory Bowel Disease ..:

Gutiérrez Casbas, A ; Rodríguez-Lago, I ; Marín-Jiménez, I...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i182-i184 , 2024

Link: https://doi.org/10.1093/..

5

P1023 Variability in Mesalazine Management for Ulcerative P..:

Bastida Paz, G ; Ceballos, D ; Ricart, E...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1849-i1849 , 2024

Link: https://doi.org/10.1093/..

6

P1149 Risk of Clostridioides difficile infection in patient..:

Martinez Lozano, H ; Saralegui Gonzalez, P ; Fueyo Peláez, P R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2058-i2058 , 2024

Link: https://doi.org/10.1093/..

7

P416 The impact of remission on healthcare resource utilisa..:

Patel, K V ; Salmon, P ; Marin-Jiménez, I...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i544-i546 , 2023

Link: https://doi.org/10.1093/..

8

P634 Ustekinumab and vedolizumab as first-line biological t..:

Calafat Sard, M ; Pascual, I ; Nos, P...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i766-i767 , 2023

Link: https://doi.org/10.1093/..

9

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C..:

Laserna-Mendieta, E.J. ; Salvador-Martín, S. ; Arias, A....
Biomedicine & Pharmacotherapy. 159 (2023) - p. 114225 , 2023

Link: https://doi.org/10.1016/..

10

P654 Controversies in the management of anti-TNF therapy in..:

Gonzalez Lama, Y ; Ricart, E ; Carpio, D...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i782-i783 , 2023

Link: https://doi.org/10.1093/..

11

P436 Efficacy and safety of intravenous ustekinumab re-indu..:

Schreiber, S W ; Lee, S ; van der Woude, C J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i564-i566 , 2023

Link: https://doi.org/10.1093/..

12

Treatment patterns and intensification within 5 year of fol..:

Bastida, G. ; Marín-Jiménez, I. ; Forés, A....
Digestive and Liver Disease. 54 (2022) 1 - p. 76-83 , 2022

Link: https://doi.org/10.1016/..

13

Inflammatory Bowel Disease (IBD) and immunosuppression do n..:

Zabana Abdo, Y ; Marín-Jiménez, I ; Rodríguez-Lago, I...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S553-S554 , 2021

Link: https://doi.org/10.1093/..

14

Manejo de los efectos adversos de apremilast desde un abord..:

Daudén Tello, E. ; Alonso Suárez, J. ; Beltrán Catalán, E....
Actas Dermo-Sifiliográficas. 112 (2021) 2 - p. 134-141 , 2021

Link: https://doi.org/10.1016/..

15

Multidisciplinary Management of the Adverse Effects of Apre..:

Daudén Tello, E. ; Alonso Suárez, J. ; Beltrán Catalán, E....
Actas Dermo-Sifiliográficas (English Edition). 112 (2021) 2 - p. 134-141 , 2021

Link: https://doi.org/10.1016/..